Related Experiment Videos
Protective activity of Lentinan in experimental tuberculosis
Nadya Markova1, Vesselin Kussovski, Ivanka Drandarska
1Department of Pathogenic Bacteria, Institute of Microbiology, Bulgarian Academy of Sciences, 26 G. Bonchev St., 1113 Sofia, Bulgaria. semahead@geobiz.net
International Immunopharmacology
|August 30, 2003
Summary
Lentinan demonstrates protective effects against Mycobacterium tuberculosis infection by enhancing host immune responses. This study shows Lentinan administration reduces tuberculosis bacterial load in mice.
Area of Science:
- Immunology
- Microbiology
- Pharmacology
Background:
- Tuberculosis remains a significant global health challenge.
- Developing effective therapeutic strategies against Mycobacterium tuberculosis is crucial.
Purpose of the Study:
- To investigate the protective effects of Lentinan against Mycobacterium tuberculosis infection.
- To evaluate Lentinan's impact on host immune responses in vitro and in vivo.
Main Methods:
- In vitro and in vivo mouse models were utilized.
- Lentinan was administered intraperitoneally before infection.
- Key parameters monitored included body temperature, spleen weight, bacterial CFU counts, and histomorphology.
- Peritoneal macrophage functions were assessed in vitro.
Main Results:
- Lentinan administration significantly reduced Mycobacterium tuberculosis CFU counts in spleen, liver, and lung.
- Treated mice showed improved body temperature and spleen weight.
- Peritoneal macrophages exhibited enhanced activity, including increased H2O2 production and improved bacterial killing.
- Histomorphological analysis indicated reduced infection severity.
Conclusions:
- Lentinan exhibits significant protective effects against Mycobacterium tuberculosis infection.
- Lentinan administration potentiates host defense mechanisms, reducing mycobacterial burden.
- Lentinan is a promising agent for tuberculosis management.